Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Wolfgang Gaebel; Andreas Schreiner; Paul Bergmans; Rosario de Arce; Frédéric Rouillon; Joachim Cordes; Lars Eriksson; Enrico Smeraldi

首页> 外文期刊>Neuropsychopharmacology >Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

【24h】

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

机译：利培酮长效注射与喹硫平预防精神分裂症和精神分裂症的复发：一项长期，开放标签，随机临床试验的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuropsychopharmacology》 |2011年第2期|共1页
作者
Wolfgang Gaebel; Andreas Schreiner; Paul Bergmans; Rosario de Arce; Frédéric Rouillon; Joachim Cordes; Lars Eriksson; Enrico Smeraldi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类神经科学;
关键词

相似文献

外文文献
中文文献
专利

1. Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial [J] . Wolfgang Gaebel, Andreas Schreiner, Paul Bergmans, Neuropsychopharmacology . 2010,第12期

机译：血糖酮长期以来的血糖酮的复发预防和血基表达障碍血糖喹啉：长期，开放标签，随机临床试验的结果
2. Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE) [J] . Enrico Smeraldi, Roberto Cavallaro, Vera Folnegovi?-?malc, Therapeutic advances in psychopharmacology. . 2013,第4期

机译：精神分裂症和精神分裂症患者的长期缓解：利培酮长效注射与喹硫平预防复发试验（ConstaTRE）的结果
3. Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial [J] . Laties Alan M., Flach Allan J., Baldycheva Irina, Journal of psychopharmacology . 2015,第Pta1期

机译：喹硫平与利培酮在长期治疗精神分裂症或精神分裂症患者中的致畸作用：一项随机，开放标签，由眼科医生掩盖的灵活剂量非劣效性试验
4. Prevention of relapses in the bipolar I disorder: a comparative study between quetiapine monotherapy vs. quetiapine-valproate combined therapy [C] . PETRU IFTENI, VICTORIA BURTEA, CORNELIU MOSOIU WSEAS International Conferences . 2009

机译：预防双极I紊乱中的复发：喹硫代单药治疗的比较研究与喹硫氨酸 - 戊醛组合治疗
5. Long-term comparison of bone regeneration between immediate and conventional loading of implants placed in fresh extracted sockets in periodontally compromised patients: 6-year randomized clinical trial. [D] . Alqahtani, Nabeeh Abdullah. 2014

机译：在牙周病患者中，在新鲜的拔牙窝中立即和常规负载的种植体之间进行骨再生的长期比较：6年随机临床试验。
6. Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term Open-Label Randomized Clinical Trial [O] . Wolfgang Gaebel, Andreas Schreiner, Paul Bergmans, 2011

机译：利培酮长效注射与喹硫平预防精神分裂症和精神分裂症的复发：一项长期开放标签随机临床试验的结果
7. Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial [O] . Gaebel, Wolfgang, Schreiner, Andreas, Bergmans, Paul, 2010

机译：利培酮长效注射与喹硫平预防精神分裂症和精神分裂症的复发：一项长期，开放标签，随机临床试验的结果

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

著录项

相似文献

相关主题

期刊订阅